These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 6042978)

  • 1. Correlation between renal function and serum half-life of kanamycin and its application to dosage adjustment.
    Sorenen AW; Szabo L; Pedersen A; Scharff A
    Postgrad Med J; 1967 May; ():Suppl:37-43. PubMed ID: 6042978
    [No Abstract]   [Full Text] [Related]  

  • 2. Kanamycin serum half-life and renal function: age and sex.
    Nielsen B; Sorensen AW; Szabo L; Pedersen EA; Scharff A
    Dan Med Bull; 1973 Oct; 20(5):144-9. PubMed ID: 4770767
    [No Abstract]   [Full Text] [Related]  

  • 3. [Measurement of streptomycin and danamycin in serum. Preliminary results in patients with impaired renal function].
    Jepsen OB; Ornsholt J
    Ugeskr Laeger; 1968 Dec; 130(50):2169-73. PubMed ID: 5707938
    [No Abstract]   [Full Text] [Related]  

  • 4. Computer-calculated kanamycin dosage regimen and monitoring.
    Ritschel WA; Banarer M; Lau-Chang EF
    Int J Clin Pharmacol Biopharm; 1977 Mar; 15(3):121-5. PubMed ID: 844931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dosage regime for kanamycin, gentamicin and digoxin. Presentation of a slide-rule for the calculation of creatinine clearance and doses of drugs].
    Kampmann JP; Kristensen M; Siersbaek-Nielsen K; Christiansen NJ; Lumholtz B; Køolendorf K; Hansen JM
    Ugeskr Laeger; 1974 Dec; 137(1):1-6. PubMed ID: 4454093
    [No Abstract]   [Full Text] [Related]  

  • 6. Kanamycin dosage in renal failure.
    Healy JK; Drum PJ; Elliott AJ
    Aust N Z J Med; 1973 Oct; 3(5):474-9. PubMed ID: 4521430
    [No Abstract]   [Full Text] [Related]  

  • 7. Kanamycin in children: pharmacology and lack of toxicity of an increased dosage regimen.
    Hieber JP; Kusmiesz H; Nelson JD
    J Pediatr; 1980 Jun; 96(6):1089-91. PubMed ID: 6768866
    [No Abstract]   [Full Text] [Related]  

  • 8. [Study of the concentration of Kanamycin in the blood serum and lung tissue of man].
    Farago E; Kish Ia; Fabian E; Molnar E
    Antibiotiki; 1974 Dec; 19(12):1073-5. PubMed ID: 4447346
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of serum creatinine concentration and kanamycin half-life. Therapeutic implications.
    Cutler RE; Orme BM
    JAMA; 1969 Jul; 209(4):539-42. PubMed ID: 5819419
    [No Abstract]   [Full Text] [Related]  

  • 10. [Nil nocere! Irreversible loss of hearing under kanamycin treatment in kidney insufficiency].
    Rindfleisch U; Thieler H; Spieske C
    Z Arztl Fortbild (Jena); 1974 Feb; 68(4):175-8. PubMed ID: 4838429
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pharmacokinetics of kanamycin after subcutaneous and intravenous administration in dogs].
    Calvo Wieland A; Ehinger AM; Kietzmann M; Nolte I
    Berl Munch Tierarztl Wochenschr; 2001; 114(1-2):57-60. PubMed ID: 11225500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacology of kanamycin in premature infants.
    Simon HJ; Axline SG
    Ann N Y Acad Sci; 1966 Jun; 132(2):1020-5. PubMed ID: 5227775
    [No Abstract]   [Full Text] [Related]  

  • 13. Absorption and excretion of intraperitoneally administered kanamycin sulfate.
    Pissiotis CA; Nichols RL; Condon RE
    Surg Gynecol Obstet; 1972 Jun; 134(6):995-8. PubMed ID: 5032398
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparative creatine-creatinine studies in the scope of oral creatine loading in dermatomyositis and progressive scleroderma].
    Kreysel HW
    Hautarzt; 1966 Sep; 17(9):399-406. PubMed ID: 5997316
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between area under the concentration versus time curve of cyclosporin A, creatinine clearance, hematocrit value, and other clinical factors in Japanese renal transplant patients.
    Shibata N; Hoshino N; Minouchi T; Yamaji A; Park K; Tomoyoshi T; Abe H; Kodama M
    Int J Clin Pharmacol Ther; 1998 Apr; 36(4):202-9. PubMed ID: 9587046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computer-assisted prescribing of kanamycin for patients with renal insufficiency.
    Mawer GE; Lucas SB; Knowles BR; Stirland RM
    Lancet; 1972 Jan; 1(7740):12-5. PubMed ID: 4108815
    [No Abstract]   [Full Text] [Related]  

  • 17. Kanamycin in the treatment of patients with diminished kidney function.
    Ory EM; Williams TW; Camp FA; Regester RF; Morgen RO
    Ann N Y Acad Sci; 1966 Jun; 132(2):933-40. PubMed ID: 5227782
    [No Abstract]   [Full Text] [Related]  

  • 18. [The plasma level of kanamycin after intravenous and intramuscular injections in horses].
    Klee S; Nürnberger MC; Keller H; Ungemach FR
    Tierarztl Prax; 1996 Aug; 24(4):368-72. PubMed ID: 9012022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of renal function on the pharmacokinetics of palifermin.
    Gillespie B; Zia-Amirhosseini P; Salfi M; Kakkar T; Wang J; Gupta S; Smith B; Robson R; Sullivan JT
    J Clin Pharmacol; 2006 Dec; 46(12):1460-8. PubMed ID: 17101745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a digital computer programme as a guide to the prescribing of kanamycin in patients with renal insufficiency.
    Knowles BR; Lucas SB; Mawer GE; Stirland RM; Tooth JA
    Br J Pharmacol; 1971 Oct; 43(2):481P-482P. PubMed ID: 5158251
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.